NewsBenzinga트루이스트 증권, 레볼루션 메디신스 투자의견 ‘매수’ 재확인···목표주가 261달러로 상향 트루이스트 증권, 레볼루션 메디신스 투자의견 ‘매수’ 재확인···목표주가 261달러로 상향 Benzinga 2026.11.05 16:00 (GMT+0) Open on Benzinga Other news Backpack Exchange Designated by CFTC as a Contract Market, Now Holding Both Trading and Clearing Qualifications All the questions Nvidia should answer on Tuesday — but probably won’t NYSE Parent ICE to Custody Abra's Institutional Crypto Loan Collateral Dear Klarna Stock Fans, Mark Your Calendars for November 17 Dear Starbucks Stock Fans, Mark Your Calendars for November 17 Freedom Holding Corp. Reports 81% Increase in Quarterly Revenue to $910.1 Million
Backpack Exchange Designated by CFTC as a Contract Market, Now Holding Both Trading and Clearing Qualifications